As of 2025-06-09, the Relative Valuation of Jiangsu Hengrui Medicine Co Ltd (600276.SS) is 23.93 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 53.80 CNY, the upside of Jiangsu Hengrui Medicine Co Ltd based on Relative Valuation is -55.5%.
The range of the Relative Valuation is 20.15 - 30.52 CNY.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 28.5x | 24.2x |
| Forward P/E multiples | 17.5x - 22.0x | 19.0x |
| Fair Price | 20.15 - 30.52 | 23.93 |
| Upside | -62.5% - -43.3% | -55.5% |
| Date | P/E |
| 2025-06-06 | 50.16 |
| 2025-06-05 | 50.24 |
| 2025-06-04 | 51.55 |
| 2025-06-03 | 51.17 |
| 2025-05-30 | 51.04 |
| 2025-05-29 | 50.44 |
| 2025-05-28 | 50.58 |
| 2025-05-27 | 49.81 |
| 2025-05-26 | 49.74 |
| 2025-05-23 | 50.81 |
| 2025-05-22 | 51.84 |
| 2025-05-21 | 52.16 |
| 2025-05-20 | 50.77 |
| 2025-05-19 | 49.84 |
| 2025-05-16 | 50.21 |
| 2025-05-15 | 50.06 |
| 2025-05-14 | 49.32 |
| 2025-05-13 | 47.77 |
| 2025-05-12 | 47.26 |
| 2025-05-09 | 49.24 |
| 2025-05-08 | 48.07 |
| 2025-05-07 | 48.03 |
| 2025-05-06 | 47.55 |
| 2025-04-30 | 47.64 |
| 2025-04-29 | 46.25 |
| 2025-04-28 | 46.59 |
| 2025-04-25 | 46.87 |
| 2025-04-24 | 47.67 |
| 2025-04-23 | 47.64 |
| 2025-04-22 | 47.52 |
| 2025-04-21 | 45.84 |
| 2025-04-18 | 44.75 |
| 2025-04-17 | 45.48 |
| 2025-04-16 | 45.59 |
| 2025-04-15 | 45.01 |
| 2025-04-14 | 45.57 |
| 2025-04-11 | 45.11 |
| 2025-04-10 | 45.22 |
| 2025-04-09 | 44.96 |
| 2025-04-08 | 45.41 |
| 2025-04-07 | 45.41 |
| 2025-04-03 | 47.59 |
| 2025-04-02 | 47.41 |
| 2025-04-01 | 48.30 |
| 2025-03-31 | 45.87 |
| 2025-03-28 | 45.32 |
| 2025-03-27 | 45.12 |
| 2025-03-26 | 43.10 |
| 2025-03-25 | 41.84 |
| 2025-03-24 | 41.35 |